Handling Three Billion letter gene sequences

Launched in 1990, the Human Genome Project was a 13-year, multi-billion-dollar global effort to sequence the human genome. Founded in 1998, Illumina, an applied genomics company, revolutionized the field with next-generation sequencing (NGS) technology. This innovation dramatically reduced the time and cost required to sequence DNA, enabling the sequencing of thousands of human genomes for a fraction of the cost compared to the Human Genome Project.

OvationData partnered with Illumina to deliver a scalable, high-throughput solution capable of handling the increased demand for genome sequencing. The system provided ultra-high throughput, scalability, speed, and reliability, optimizing analysis and reducing costs and management overhead.

Today, Illumina's technology enables human whole-genome sequencing in under 12 hours for less than $500, an improvement from the 13 years and $3 billion required two decades ago. This breakthrough has made DNA studies more accessible, particular